Research study Program year 2025 Source: CMS Open Payments

A Phase III Multicenter Randomized Open Label Study Comparing Atezolizumab Anti PD L1 Antibody

Research payments

$3,243,179

711 payments

Through program year 2025, $3,243,179 in research payments was reported against A Phase III Multicenter Randomized Open Label Study Comparing Atezolizumab Anti PD L1 Antibody, across 711 payments.

Paid by (largest first)
Roche Products Limited; Hoffmann-La Roche Limited; Genentech, Inc.
ClinicalTrials.gov
No trial number was reported for this study

By program year

7 rows
Year Kind Amount Payments
2025 Research $175,820 18
2024 Research $286,091 46
2023 Research $308,152 134
2022 Research $560,301 102
2021 Research $649,887 143
2020 Research $511,794 158
2019 Research $751,135 110

Breakdown

Who paid Research payments · program years 2019–2025
  1. Roche Products Limited $2,473,117 513 payments
  2. Hoffmann-La Roche Limited $723,152 195 payments
  3. Genentech, Inc. $46,910 3 payments
Who received the money Research payments · program years 2019–2025
  1. Baptist Medical Center Teaching hospital · FL $501,471 153 payments
  2. Sarah Cannon Research Institute LLC Organisation paid for research $492,369 90 payments
  3. Memorial Sloan Kettering Cancer Center Organisation paid for research $266,610 19 payments
  4. University of Maryland Baltimore State of Maryland Organisation paid for research $217,152 15 payments
  5. University of Maryland Baltimore Organisation paid for research $179,352 13 payments
  6. Cancer Center Of Kansas PA Organisation paid for research $156,769 46 payments
  7. Biomedical Research Alliance Of New York LLC Organisation paid for research $154,065 48 payments
  8. Rochester General Hospital Teaching hospital · NY $129,963 13 payments
  9. Comptroller of Maryland Central Payroll Bureau,University of Maryland,,Baltimore Organisation paid for research $100,663 6 payments
  10. Cedars-Sinai Medical Center Teaching hospital · CA $97,465 23 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

5 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record